![](/img/cover-not-exists.png)
SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
Campo, R., DeJesus, E., Bredeek, U. F., Henry, K., Khanlou, H., Logue, K., Brinson, C., Benson, P., Dau, L., Wang, H., White, K., Flaherty, J., Fralich, T., Guyer, B., Piontkowsky, D.Volume:
56
Language:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/cis1203
Date:
June, 2013
File:
PDF, 513 KB
english, 2013